| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Tibolone | Tibolone EP Impurity A | VE008259 | View CAS 105186-35-4 |
| Tibolone | Tibolone EP Impurity B | VE008260 | View CAS 105186-34-3 |
| Tibolone | Tibolone EP Impurity C | VE008261 | View CAS 1162-60-3 |
| Tibolone | Tibolone EP Impurity D | VL146002 | View CAS 32297-45-3 |
| Tibolone | Tibolone EP Impurity E | VE008262 | View CAS 105186-33-2 |
| Tibolone | Tibolone Impurity | VL146001 | View CAS 5630-53-5 |
[rfq_list]
| Catalogue No. | VE008262 |
| CAS No. | 105186-33-2 |
| Molecular Formula | C23H34O3 |
| Molecular Weight | 358.51 g/mol |
| Parent drug | Tibolone |
| IUPAC Name | (7a, 17a)-3, 3-Dimethoxy-7-methyl-19-norpregn-5(10)-en-20-yn-17-ol |
| Synonyms | Tibolone 3-Dimethyl Ketal |
| References | Sci-Hub, Effect of Tibolone and its metabolites on vascular endothelial growth factor (VEGF) isoforms 121 and 165 in ishikawa cells, 10.1016/s0015-0282(02)03814-1. (2022). Retrieved January 27, 2022, from Sci-hub.ee website: https://sci-hub.ee/10.1016/s0015-0282(02)03814-1 |
| Status | In-stock |
| ListName | Tibolone EP Impurity E |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
